The global Drugs for Vulvovaginal Candidiasis Market is benefiting from increasing awareness of vaginal fungal infections and the need for timely treatment. As millions of women experience VVC annually, pharmaceutical companies continue to invest in innovative antifungal therapies offering improved efficacy and reduced recurrence. According to The Insight Partners, the Drugs for Vulvovaginal...